The HER2 antibody–sialidase conjugate also increases antibody affinity and destroys tumor-derived sialoglycans, thus boosting anti-tumor immune response and extending the survival of tumor-bearing animals [105]. The gene discussed is ERBB2; the disease is neoplasm.